News on this topic
Profile picture of CNN.com
CNN.com
Credibility C+
 Apr 15 25
Pfizer ends development of potential pill obesity treatment: Pfizer is ending the development of its potential once-daily pill treatment for obesity before ...
cnn.com/2025/04/14/health/pfizer-pill-obesity-treatment/
Pfizer ends development of potential pill obesity treatment
12
356
Profile picture of Trinidad and Tobago Guardian
Trinidad and Tobago Guardian
B−
 Apr 14 25
Pfizer ends development of potential pill obesity treatment: Pfizer is ending the development of its potential once-daily pill treatment for obesity before ...
apnews.com/article/pfizer-discontinues-potential-obesity-pill-ab583f34c251be43f589d762dadff821
Pfizer ends development of potential pill obesity treatment
15
90
9
2
More articles on this subject
Previous
0
0 0
Profile picture of Die Presse
Die Presse
B
 Apr 15 25
Pfizer stops development of its weight-loss pill: The US company is stopping its oral anti-obesity therapy - | and is losing further ground in the race against ...
diepresse.com/19583260/pfizer-stoppt-entwicklung-seiner-abnehmpille
Pfizer stops development of its weight-loss pill
0
1
Profile picture of The Financial Express
The Financial Express
C−
 Apr 15 25
Why Pfizer scrapped obesity pill development: Weight-loss drug market shares explored
financialexpress.com/business/healthcare-why-pfizer-scraps-obesity-pill-development-weight-loss-drug-market-shares-explored-3809861/
Why Pfizer scrapped obesity pill development: Weight-loss drug market ...
0
0
Profile picture of deraktionaer.de
deraktionaer.de
C
 Apr 15 25
Pfizer disappointed - | Takeover speculation heats up: Pfizer stops obesity drug danugliprone, share price rises due to takeover speculation from Viking ...
deraktionaer.de/artikel/pharma-biotech/pfizer-enttaeuscht-uebernahmespekulationen-kochen-hoch-20378465.html
Pfizer disappointed - | Takeover speculation heats up
0
0
Profile picture of The Hill (newspaper)
The Hill
B
 Apr 15 25
Pfizer will end development of daily anti-obesity pill due to liver injury: Pfizer is stopping development of its experimental oral GLP-1 drug for obesity ...
trib.al/EYNdJgk
Pfizer will end development of daily anti-obesity pill due to liver injury
0
54
Profile picture of PBS
PBS
A−
 Apr 15 25
Pfizer abandons potential obesity treatment pill: The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials ...
pbs.org/newshour/health/pfizer-abandons-potential-obesity-treatment-pill
Pfizer abandons potential obesity treatment pill
0
22
Profile picture of Handelsblatt
Handelsblatt
B+
 Apr 14 25
Pfizer: Liver damage in study - | US company cancels diet pill: The US pharmaceutical company Pfizer has suffered another setback and is halting research into a ...
handelsblatt.com/unternehmen/industrie/pfizer-leberschaeden-in-studie-us-konzern-streicht-diaetmittel/100121480.html
Pfizer: Liver damage in study - | US company cancels diet pill
0
5
Profile picture of The Press Democrat
The Press Democrat
A−
 Apr 14 25
Pfizer ends development of potential pill obesity treatment: Pfizer is ending the development of its potential once-daily pill treatment for obesity before ...
pressdemocrat.com/article/trending/pfizer-ends-development-of-potential-pill-obesity-treatment/
Pfizer ends development of potential pill obesity treatment
0
0
Profile picture of Fox Business
Fox Business
D+
 Apr 14 25
Pfizer will end development of daily weight-loss pill after liver injury: Pfizer is facing another setback with its weight-loss pill, danuglipron ...
foxbusiness.com/lifestyle/pfizer-end-development-daily-weight-loss-pill-after-liver-injury
Pfizer will end development of daily weight-loss pill after liver injury
0
24
Profile picture of Orlando Sentinel
Orlando Sentinel
B+
 Apr 14 25
Pfizer ends development of potential pill obesity treatment: The drugmaker said that it would stop studying danuglipron after a participant in one of its trials ...
bostonherald.com/2025/04/14/pfizer-obesity-treatment-pill/
Pfizer ends development of potential pill obesity treatment
0
1
Profile picture of Bloomberg
Bloomberg
B+
 Apr 14 25
Fed’s Waller Expects Tariff Impact on Inflation to Be Temporary
bloomberg.com/news/articles/2025-04-14/fed-s-waller-expects-tariff-impact-on-inflation-to-be-temporary
Fed’s Waller Expects Tariff Impact on Inflation to Be Temporary
0
5
0
0 1
0
6
0
0
Profile picture of Inquirer.net
Inquirer.net Apr 14 25
Pfizer ends development of potential pill obesity treatment: UNITED STATES - | Pfizer is ending the development of its potential once-daily pill treatment for ...
business.inquirer.net/519893/pfizer-ends-development-of-potential-pill-obesity-treatment
Pfizer ends development of potential pill obesity treatment
0
4
Profile picture of Deccan Herald
Deccan Herald
C
 Apr 14 25
Pfizer ends development of weight-loss pill danuglipron: Pfizer halts the development of its experimental weight-loss pill danuglipron after a patient suffered ...
deccanherald.com/health/healthcare/pfizer-ends-development-of-weight-loss-pill-danuglipron-2-3493114
Pfizer ends development of weight-loss pill danuglipron
0
0
Profile picture of deraktionaer.de
deraktionaer.de
C
 Apr 14 25
Obesity market: Pfizer throws in the towel - | Novo Nordisk and Co. are gaining ground
deraktionaer.de/artikel/pharma-biotech/adipositas-markt-pfizer-wirft-das-handtuch-novo-nordisk-und-co-ziehen-an-20378435.html
Obesity market: Pfizer throws in the towel - | Novo Nordisk and Co ...
0
0
Profile picture of The Wall Street Journal
The Wall Street Journal
B
 Apr 14 25
Pfizer Halts Development of Weight-Loss Pill: Danuglipron was the latest drug investors were hinging hope on to enter obesity market
wsj.com/health/pharma/pfizer-halts-development-of-weight-loss-pill-f3045796
Pfizer Halts Development of Weight-Loss Pill
0
0
Profile picture of CNBC
CNBC
B
 Apr 14 25
Pfizer scraps daily weight loss pill after liver injury in one patient
cnbc.com/2025/04/14/pfizer-scraps-daily-weight-loss-pill-danuglipron.html
Pfizer scraps daily weight loss pill after liver injury in one patient
0
7
Profile picture of Bloomberg
Bloomberg
B+
 Apr 14 25
Pfizer (PFE) Abandons Obesity Pill After Liver Injury in Major Setback: Pfizer Inc. will stop developing an obesity pill that has been closely watched by ...
bloomberg.com/news/articles/2025-04-14/pfizer-pfe-abandons-obesity-pill-after-liver-injury-in-major-setback
Pfizer (PFE) Abandons Obesity Pill After Liver Injury in Major Setback
0
3
0
2 2
Next
Similar to This
Previous
3
8
Profile picture of STAT
STAT Jun 08
Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and more
statnews.com/pharmalot/2026/06/08/lilly-pfizer-obesity-drug-trial-data-roche-deal/
Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data ...
0 similar articles
0
0
19
16 1
Profile picture of The Indian Express
The Indian Express
C
 Jun 08
Pfizer’s new weight-loss shot: Can one injection a month change obesity treatment as we know it?
indianexpress.com/article/health-wellness/pfizer-monthly-weight-loss-shot-berobenatide-trial-results-10728976/
Pfizer’s new weight-loss shot: Can one injection a month change obesity ...
0
1
Profile picture of deraktionaer.de
deraktionaer.de
C
 Feb 04
Pfizer: Too high a gamble in the race with Novo Nordisk?: Time will tell whether the deal pays off.
deraktionaer.de/artikel/pharma-biotech/pfizer-zu-hoch-gepokert-im-rennen-mit-novo-nordisk-20394822.html
Pfizer: Too high a gamble in the race with Novo Nordisk?
0 similar articles
0
0
1
0 0
1
3 0
4
0
Profile picture of marketwatch.com
marketwatch.com
B
 Nov 16 25
Pfizer won its fight to buy an obesity-drug maker. It took an extra $1.7 billion and a phone call.
marketwatch.com/story/pfizer-won-its-fight-to-buy-an-obesity-drug-maker-it-took-an-extra-1-7-billion-and-a-phone-call-a9670e80
Pfizer won its fight to buy an obesity-drug maker. It took an extra $1 ...
0 similar articles
0
3
Profile picture of CNBC
CNBC
B
 Nov 14 25
Novo Nordisk's leadership strategy tested as shareholders signal frustration ahead of vote on board revamp
cnbc.com/2025/11/14/novo-nordisks-strategy-tested-as-investors-push-back-on-board-revamp.html
Novo Nordisk's leadership strategy tested as shareholders signal ...
2 similar articles
1
0
Profile picture of Reuters
Reuters
A
 Nov 10 25
Metsera falls after accepting up to $10 billion offer from Pfizer: Shares of Metsera fell over 15% in early trading on Monday, after the weight-loss drug ...
reuters.com/sustainability/boards-policy-regulation/novo-nordisk-shares-rise-after-dropping-metsera-bid-2025-11-10/
Metsera falls after accepting up to $10 billion offer from Pfizer
40 similar articles
6
5 2
Profile picture of Reuters
Reuters
A
 Nov 01 25
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid: Pfizer on Friday filed a lawsuit against Metsera and Novo Nordisk , saying Metsera breached its ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-gets-us-antitrust-clearance-metsera-deal-2025-10-31/
Pfizer sues Metsera, Novo Nordisk over rival obesity drug bid
Key FactsPfizer Files Suit Over Metsera Acquisition Dispute
Nov 1, 2025 · Reading time: ~45 sec.
Summary created with AI assistance · Source: reuters.com
  • Pfizer accused Metsera of breaching merger terms by declaring Novo Nordisk's $8.5 billion offer superior.

  • A temporary restraining order is requested to stop Metsera from ending the agreement prematurely.

  • The Federal Trade Commission granted Pfizer early antitrust approval for its $7.3 billion Metsera acquisition.

  • Novo Nordisk denied the allegations and pledged a vigorous defense in any ensuing litigation.
    • Pfizer's claims against Novo Nordisk are meritless, and we will vigorously defend ourselves in any litigation.
    — A Novo spokesperson regarding Pfizer's legal claims.
17 similar articles
8
17 6
Profile picture of deraktionaer.de
deraktionaer.de
C
 Oct 14 25
Attack on Novo Nordisk and Eli Lilly: Mega-financing for obesity play: Kailera Therapeutics raises $600 million for obesity drug development.
deraktionaer.de/artikel/pharma-biotech/angriff-auf-novo-nordisk-und-eli-lilly-mega-finanzierung-fuer-adipositas-play-20388313.html
Attack on Novo Nordisk and Eli Lilly: Mega-financing for obesity play
0 similar articles
0
1
Profile picture of deraktionaer.de
deraktionaer.de
C
 Sep 22 25
Pfizer on the verge of a blockbuster deal: Attack on Novo Nordisk and Eli Lilly: Pfizer plans to buy Metsera for $7.3 billion to expand in the obesity market.
deraktionaer.de/artikel/pharma-biotech/pfizer-vor-hammer-deal-attacke-auf-novo-nordisk-und-eli-lilly-20386934.html
Pfizer on the verge of a blockbuster deal: Attack on Novo Nordisk and Eli ...
27 similar articles
0
0
Profile picture of New Atlas
New Atlas May 05 25
The Ozempic pill is on the way, but one big US company won't be making it: The race for oral GLP-1 weight loss drugs is intense. Pfizer drops a candidate ...
newatlas.com/disease/obesity/ozempic-weight-loss-pill/
The Ozempic pill is on the way, but one big US company won't be ...
0
1
Profile picture of finanzen.net
finanzen.net
C
 Apr 22 25
Novo Nordisk shares fall: Eli Lilly intensifies competition: Novo Nordisk shares have been in a correction for some time. Growing competition from US rival Eli ...
finanzen.net/nachricht/aktien/abnehm-medikamente-im-fokus-novo-nordisk-aktie-verliert-zunehmende-konkurrenz-durch-eli-lilly-14407978
Novo Nordisk shares fall: Eli Lilly intensifies competition
2 similar articles
0
0
Profile picture of Quartz
Quartz
B+
 Jul 12 24
Pfizer's weight loss pill, Novo Nordisk's setback, and the FTC vs. drug middlemen: Pharma news roundup
qz.com/pfizer-fda-novo-nordisk-ftc-1851588254
Pfizer's weight loss pill, Novo Nordisk's setback, and the FTC vs ...
1 similar article
0
0 0
Profile picture of Quartz
Quartz
B+
 Jul 11 24
Pfizer says it is advancing development of a once-daily weight loss pill: The pharma giant said that obesity is 'key therapeutic area' for the company
qz.com/pfizer-weight-loss-pill-1851586916
Pfizer says it is advancing development of a once-daily weight loss pill
12 similar articles
0
4 0
Profile picture of Reuters
Reuters
A
 Dec 01 23
Pfizer drops twice-daily version of obesity pill over side effects: Pfizer (PFE.N) said on Friday it would not advance a twice-daily version of oral weight-loss ...
reuters.com/business/healthcare-pharmaceuticals/pfizer-drops-plan-study-twice-daily-obesity-pill-late-stage-studies-2023-12-01/
Pfizer drops twice-daily version of obesity pill over side effects
8 similar articles
3
6 5
Next